Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode PsychosisValeria Mondelli, Paola Dazzan, Simone Ciufolini et al.|Schizophrenia Bulletin|2015Cited by 278
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialJ.F.W. Deakin, Graham Dunn, Thomas R. E. Barnes et al.|The Lancet Psychiatry|2018Cited by 180
Cortical Folding Defects as Markers of Poor Treatment Response in First-Episode PsychosisLena Palaniyappan, Paola Dazzan, Tiago Reis Marques et al.|JAMA Psychiatry|2013Cited by 122
Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of GyrificationLena Palaniyappan, Paola Dazzan, Tiago Reis Marques et al.|Schizophrenia Bulletin|2016Cited by 53
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R. Krynicki, Rachel Upthegrove, Paola Dazzan et al.|Brain Behavior and Immunity|2020Cited by 38